Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132163) titled 'Efficacy, Safety, and Patient-Reported Outcomes of Oxycodone Sustained-Release Tablets in Patients with Solid Tumor-Related Cancer Pain: A Multicenter, Prospective Real-World Study' on Sept. 10.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Nanxishan Hospital of Guangxi Zhuang Autonomous Region
Condition:
Chronic cancer pain
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-15
Target Sample Size: Oxycodone sustained-release tablet group:420;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=3324...